# Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms

> **NCT00408954** · PHASE2 · COMPLETED · sponsor: **Pfizer** · enrollment: 27 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **DRUG:** UK-369,003
- **DRUG:** UK-369,003

## Key facts

- **NCT ID:** NCT00408954
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2010-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408954, "Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00408954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*